NCT06089161NARecruiting

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

University of Miami

Start Date

3/19/2024

Completion Date

5/31/2028

Summary

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Eligibility Criteria

Age Range: 60 years to 85 years

Inclusion Criteria: * Self-reported race/ethnicity as African American, African, Caribbean or black * Ages 60-85 years * accessible by phone * OSA diagnosis * consent, including permission to release medical data Exclusion Criteria: * progressive illnesses in which disability or death is expected within 1 year * impaired cognitive/ functional ability precluding participation * intention to move within the year * and a family member currently enrolled.

Interventions

OTHER

Standard of Care

BEHAVIORAL

Personalized OSA Treatment

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Sleep Apnea

Locations

University of Miami

Miami, Florida 33136

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.